{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:06:18Z","timestamp":1779509178245,"version":"3.53.1"},"reference-count":42,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7155-26","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T22:09:40Z","timestamp":1779487780000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Large B-cell Lymphoma Arising in a Patient with the Long-term Remission of Left-sided Ulcerative Colitis: A Case Report"],"prefix":"10.2169","author":[{"given":"Shoma","family":"Kikukawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Nagamatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Uejima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Moriya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nara Prefecture General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Beaugerie L, Carrat F, Nahon S, et al. High risk of anal and rectal cancer in patients with anal and\/or perianal Crohn's disease. Clin Gastroenterol Hepatol 16: 892-899, 2018."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kotlyar DS, Osterman MT, Diamond RH, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 9: 36-41, 2011.","DOI":"10.1016\/j.cgh.2010.09.016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lemaitre M, Kirchgesner J, Rudnichi A, et al. Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease. JAMA 320: 1679-1686, 2018.","DOI":"10.1001\/jama.2017.16071"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ohmachi K. JSH practical guidelines for hematological malignancies, 2023: II. lymphoma-overview. Int J Hematol 121: 567-576, 2025.","DOI":"10.1007\/s12185-025-03920-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164: 536-5345, 2014.","DOI":"10.1111\/bjh.12659"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ol\u00e9n O, Smedby KE, Erichsen R, et al. Increasing risk of lymphoma over time in Crohn's disease but not in ulcerative colitis: a Scandinavian cohort study. Clin Gastroenterol Hepatol 21: 3132-3142, 2023.","DOI":"10.1016\/j.cgh.2023.04.001"},{"key":"7","unstructured":"7. Herrinton LJ, Liu L, Levin TR, et al. Incidence of hematologic malignancies in relation to inflammatory bowel disease and thiopurine use: a prospective nested case-control study. Pharmacoepidemiol Drug Saf 20: 1057-1065, 2011."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stasik K, Zawadzki M, Kowalczyk A, et al. The complex relationship between mechanisms of inflammatory bowel disease and lymphoma development. Int J Mol Sci 25: 4241, 2024.","DOI":"10.3390\/ijms25084241"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 145: 166-175, 2013.","DOI":"10.1053\/j.gastro.2013.03.044"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21: 1982-1992, 2015.","DOI":"10.1097\/MIB.0000000000000392"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med 372: 1441-152, 2015.","DOI":"10.1056\/NEJMra1403718"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zamani M, Alizadeh-Tabari S, Murad MH, et al. Risk of lymphoma in patients with inflammatory bowel disease: a systematic review and meta-analysis. Aliment Pharmacol Ther 59: 659-674, 2024.","DOI":"10.1111\/apt.17919"},{"key":"13","unstructured":"13. Russo MF, Bros\u00e9us J, Feugier P, et al. Characteristics of lymphoma in patients with inflammatory bowel disease: a systematic review. Front Med (Lausanne) 10: 1172634, 2023."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yu J, Refsum E, Helsingen LM, Wieszczy P, et al. Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study. BMJ Open Gastroenterol 10: e001037, 2023.","DOI":"10.1136\/bmjgast-2022-001037"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhou X, Zhang T, Yang Q, Wang D, et al. Hematologic malignancies in patients with inflammatory bowel disease: a nationwide registry-based analysis. Gut Liver 18: 352-361, 2024.","DOI":"10.5009\/gnl240119"},{"key":"16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","volume":"374","author":"N Brousse","year":"2009","unstructured":"16. Brousse N, Beaugerie L, Danese S, et al. Lymphoproliferative disorders in IBD patients receiving thiopurines: long-term outcomes. Lancet 374: 1617-1625, 2009.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Loftus EV Jr, Tremaine WJ, Habermann TM, et al. Lymphoma occurring in the setting of inflammatory bowel disease. Am J Gastroenterol 95: 230-235, 2000.","DOI":"10.1111\/j.1572-0241.2000.02316.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yang C, Ng SC, Shu Z, et al. Use of thiopurines and risk of lymphoma in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 12: 1042-1050, 2018.","DOI":"10.1093\/ecco-jcc\/jjy096"},{"key":"19","unstructured":"19. Siegel CA, Marden SM, Persing SM, et al. Risk of lymphoma associated with inflammatory bowel disease. Gastroenterol Hepatol (N Y) 5: 785-792, 2009."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tan CW, Wilson GE, Howat JM, Shreeve DR. Rectal lymphoma in ulcerative colitis treated with azathioprine. Eur J Gastroenterol Hepatol 13: 989-992, 2001.","DOI":"10.1097\/00042737-200108000-00022"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Khan S, Anderson GK, Eppstein AC, Eggenberger JC, Margolin DA. Ulcerative colitis and colonic lymphoma: a theoretical link. Am Surg 67: 654-656, 2001.","DOI":"10.1177\/000313480106700713"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Watanabe N, Sugimoto N, Matsushita A, et al. Association of intestinal malignant lymphoma and ulcerative colitis. Intern Med 42: 1183-1187, 2003.","DOI":"10.2169\/internalmedicine.42.1183"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schwartz LK, Kim MK, Coleman M, Lichtiger S, Chadburn A, Scherl E. Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 4: 1030-1034, 2006.","DOI":"10.1016\/j.cgh.2006.05.024"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Shibahara T, Miyazaki K, Sato D, et al. Rectal malignant lymphoma complicating ulcerative colitis treated with long-term cyclosporine A. J Gastroenterol Hepatol 21: 336-338, 2006.","DOI":"10.1111\/j.1440-1746.2006.03988.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. VanHauwaert V, Meers S, Verhoef G, et al. Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis. J Crohns Colitis 4: 683-686, 2010.","DOI":"10.1016\/j.crohns.2010.06.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Khan A, Lloyd GM, Ihedioha U, Hemingway D. Rectovesical fistula secondary to B-cell lymphoma of the rectum: a unique presentation of a rare disease. Colorectal Dis 14: e358-e359, 2012.","DOI":"10.1111\/j.1463-1318.2011.02868.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Allen PB, Laing G, Connolly A, O'Neill C. EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?. BMJ Case Rep 2013.","DOI":"10.1136\/bcr-2013-200423"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hiyama K, Terashima H, Nakano Y, et al. Primary rectal diffuse large B-cell lymphoma associated with ulcerative colitis: a case report. Clin Case Rep 3: 150-155, 2015.","DOI":"10.1002\/ccr3.185"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chang MD, Markham MJ, Liu X. Epstein-Barr virus-positive diffuse large B-cell lymphoma involving the colon in a patient with ulcerative pancolitis and polymyositis on long-term methotrexate therapy. Gastroenterol Res 9: 83-86, 2016.","DOI":"10.14740\/gr720e"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Suzuki K, Ohe R, Kabasawa T, Aung NY, Yano M. Katsumi S, et al. A case of iatrogenic immunodeficiency-associated colonic lymphoma complicating ulcerative colitis. Diagn Pathol 15: 34, 2020.","DOI":"10.1186\/s13000-020-00954-8"},{"key":"31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000522044","volume":"30","author":"S Saraiva","year":"2023","unstructured":"31. Saraiva S, Bernardo S, Fernandes S, Costa P, Correia L, Marinho RT. Primary diffuse large B-cell lymphoma of the rectum in a non-immunosuppressed patient with ulcerative colitis. GE Portuguese Journal of Gastroenterology 30: 305-310, 2023.","journal-title":"GE Portuguese Journal of Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/2341-4545","issn-type":"print"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Suzuki T, Iwamoto K, Nozaki R, Saiki Y, et al. Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report. BMC Surg 21: 50, 2021.","DOI":"10.1186\/s12893-021-01060-2"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Walinjkar S, Kumar A, Sharma P, Gupta P, Bansal N, Singla V, et al. Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report. Indian J Pathol Microbiol 64 (Special): S92-S94, 2021.","DOI":"10.4103\/IJPM.IJPM_654_19"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ogiyama H, Murayama Y, Tsutsui S, Iwasaki T, Kuriyama D, Horiki M, et al. Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy. Clin J Gastroenterol. 16: 198-205, 2023.","DOI":"10.1007\/s12328-023-01754-5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nakada T, Arihiro S, Gunji T, Ogasawara Y, Kato M, Kato T, et al. A rare case of Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis. Clin J Gastroenterol 16: 543-49, 2023.","DOI":"10.1007\/s12328-023-01811-z"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sedai H, Shrestha S, Chand V, Poddar E, Acharya S, Koirala D. Diffuse large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis: a case report. Ann Med Surg (Lond) 85: 2059-2063, 2023.","DOI":"10.1097\/MS9.0000000000000562"},{"key":"37","unstructured":"37. Hamamoto Y, Sugihara H, Hasegawa K, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma arising in ulcerative colitis: an instructive case report and literature review.. Diagn Pathol 15: 34, 2020."},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Chatterjee A, Panda I, Kakkar N, Singh H, Sharma V. EBV-related diffuse large B cell lymphoma in ulcerative colitis after brief thiopurine exposure. Arab Journal of Gastroenterology 26: 449-451, 2025.","DOI":"10.1016\/j.ajg.2025.09.015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Phan NT, Ho PT, Ma NP, et al. Diffuse large B-cell lymphoma developing on the background of long-standing ulcerative colitis: a case report. Korean J Gastroenterol 85: 537-542, 2025.","DOI":"10.4166\/kjg.2025.070"},{"key":"40","unstructured":"40. Suzuki Y, Kalambokis GN, Russell KW, Asif T. Diagnostic challenges in diffuse large B-cell lymphoma in a young liver transplant patient with ulcerative colitis: a case report. Cureus 14: e29159, 2022."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Vetro C, Romano A, Amico I, et al. Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up. World J Gastroenterol 20: 12993-3005, 2014.","DOI":"10.3748\/wjg.v20.i36.12993"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Inoo S, Iwamuro M, Tanaka T, et al. Gastric mucosa-associated lymphoid tissue lymphoma that relapsed after 11 years subsequent to achieving complete remission. Intern Med 63: 1697-1702, 2024.","DOI":"10.2169\/internalmedicine.2642-23"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7155-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T03:40:56Z","timestamp":1779507656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7155-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7155-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7155-26"}}